| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Beijing Med-pharm Extends Chinese Distribution Network
Posted on 03/30/2007 17:42:26 | Link | Post Comment
by Richard Daverman, PhD
Centient Biotech Investor
Beijing Med-Pharm Corporation (BJGP) has made another acquisition that extends its pharmaceutical distribution network in China. Beijing Med-Pharm was the winning bidder for a 63% stake in Shanghai Rongheng Pharmaceutical Co., which distributes pharmaceuticals in Shanghai, China’s largest city, with 17 million inhabitants.
Beijing Med-Pharm, based in Pennsylvania, is in the business of distributing western drugs in China. It produced $21 million in revenue in the preceding 12 months.
In January, Beijing Med-Pharm formed a joint venture with Alliance Boots, a pharmacy/distributor in the UK, to buy Guangzhou Pharma, the third largest pharmaceutical wholesaler in China (see story), which operates in Guangzhou province. As its name implies, Beijing Med-Pharma’s original distribution operations are in Beijing. The company’s stated goal is to expand its network to cover the entire country.
Rongheng distributes 400 pharmaceutical products to over 250 hospitals in Shanghai, including most of the top-tier hospitals. It had revenues of $12 million in 2006. Beijing Med-Pharm won the bidding in January, and it has now signed a final agreement with Rongheng. It expects the deal to close in Q2 of 2007, after government officials approve.
A transition team, including David Geo, CEO of Beijing Med-Pharm, has been formed, and it is already involved in running Rongheng. The current general manager of Rongheng, Zhou Jianwei, will stay on.
Besides distribution, Beijing Med-Pharm offers pre-market entry analysis, clinical trial management, product registration, market research, and marketing to physicians.
Source: CentientInvestor.com
RELATED READING:
- Watch Alert: Beijing Med-Pharm Volume Jumps 450%
- Offshoring of Biotech Research to China
- Biotech IPO Watch: Tongjitang Chinese Medicines
_____________________
Centient Biotech Investor
Beijing Med-Pharm Corporation (BJGP) has made another acquisition that extends its pharmaceutical distribution network in China. Beijing Med-Pharm was the winning bidder for a 63% stake in Shanghai Rongheng Pharmaceutical Co., which distributes pharmaceuticals in Shanghai, China’s largest city, with 17 million inhabitants.
Beijing Med-Pharm, based in Pennsylvania, is in the business of distributing western drugs in China. It produced $21 million in revenue in the preceding 12 months.
In January, Beijing Med-Pharm formed a joint venture with Alliance Boots, a pharmacy/distributor in the UK, to buy Guangzhou Pharma, the third largest pharmaceutical wholesaler in China (see story), which operates in Guangzhou province. As its name implies, Beijing Med-Pharma’s original distribution operations are in Beijing. The company’s stated goal is to expand its network to cover the entire country.
Rongheng distributes 400 pharmaceutical products to over 250 hospitals in Shanghai, including most of the top-tier hospitals. It had revenues of $12 million in 2006. Beijing Med-Pharm won the bidding in January, and it has now signed a final agreement with Rongheng. It expects the deal to close in Q2 of 2007, after government officials approve.
A transition team, including David Geo, CEO of Beijing Med-Pharm, has been formed, and it is already involved in running Rongheng. The current general manager of Rongheng, Zhou Jianwei, will stay on.
Besides distribution, Beijing Med-Pharm offers pre-market entry analysis, clinical trial management, product registration, market research, and marketing to physicians.
Source: CentientInvestor.com
RELATED READING:
- Watch Alert: Beijing Med-Pharm Volume Jumps 450%
- Offshoring of Biotech Research to China
- Biotech IPO Watch: Tongjitang Chinese Medicines
_____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
Examples
Morpheus Trading - Tue Sep 02, 2008 05:21AM
NOTE: Please click on the charts below to enlarge them [read more]
NOTE: Please click on the charts below to enlarge them [read more]
Morpheus Trading - Thu Sep 04, 2008 04:34AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Wed Sep 03, 2008 04:35AM
NOTE: Please click on the charts below to enlarge them [read more]
NOTE: Please click on the charts below to enlarge them [read more]
<< My Home | TheMoneyBlogs Home